Home
>
National Drug Code (NDC)
>
ESTRACE
ESTRACE - 0430-0722-24 - (estradiol)
Drug Information of ESTRACE
| Product NDC: | 0430-0722 |
| Proprietary Name: | ESTRACE |
| Non Proprietary Name: | estradiol |
| Active Ingredient(s): | 2 mg/1 & nbsp; estradiol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ESTRACE
| Product NDC: | 0430-0722 |
| Labeler Name: | Warner Chilcott (US), LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040197 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111226 |
Package Information of ESTRACE
| Package NDC: | 0430-0722-24 |
| Package Description: | 100 TABLET in 1 BOTTLE (0430-0722-24) |
NDC Information of ESTRACE
| NDC Code | 0430-0722-24 |
| Proprietary Name | ESTRACE |
| Package Description | 100 TABLET in 1 BOTTLE (0430-0722-24) |
| Product NDC | 0430-0722 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | estradiol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111226 |
| Marketing Category Name | ANDA |
| Labeler Name | Warner Chilcott (US), LLC |
| Substance Name | ESTRADIOL |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
